Bristol-Myers Squibb involved in developing alternative sources of TAXOL.
D002626:Chemistry, Pharmaceutical / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000096:biosynthesis* / Q000138:chemical synthesis*; D010946:Plants, Medicinal / Q000378:metabolism
D017239:Paclitaxel